1. Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma
    Si Shi et al, 2015, Disease Markers CrossRef
  2. Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system
    Jeremy Chee et al, 2017, J Cancer Res Clin Oncol CrossRef
  3. Nasopharyngeal carcinoma
    Melvin L K Chua et al, 2016, The Lancet CrossRef
  4. STAT3 mediates resistance to anoikis and promotes invasiveness of nasopharyngeal cancer cells
    Chien-Hung Lin et al, 2017 CrossRef
  5. AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines
    Zhen Gooi et al, 2017, Head Neck CrossRef
  6. Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system
    Lu-Jun Shen et al, 2015, Chin J Cancer CrossRef
  7. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma
    Rou Jiang et al, 2015, Chin J Cancer CrossRef
  8. Management of Metastatic Nasopharyngeal Carcinoma
    Roger K.C. Ngan et al, 2019 CrossRef
  9. A Nomogram for the Prediction of Prognosis in Patients With Distant Metastases of Nasopharyngeal Carcinoma
    Liang Zhao et al, 2019, Front. Oncol. CrossRef
  10. Palbociclib for the Treatment of Metastatic Nasopharyngeal Carcinoma With CDK4 Amplification: A Case Report
    Xiao-Dong Jiao et al, 2019, JCO Precision Oncology CrossRef
  11. Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells
    Bei-Ping Miao et al, 2015, Cell Mol Immunol CrossRef
  12. Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy.
    Quynh Thu Le et al, 2019, J Natl Cancer Inst CrossRef
  13. Staging of nasopharyngeal carcinoma – The past, the present and the future
    Wai Tong Ng et al, 2014, Oral Oncology CrossRef
  14. The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy
    Wei-Xiong Xia et al, 2013, PLoS ONE CrossRef
  15. Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy
    Ji Hyun Chang et al, 2016, Head Neck CrossRef
  16. Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma
    Jun Zheng et al, 2014, PLoS ONE CrossRef
  17. Individualized treatment in stage IVC nasopharyngeal carcinoma
    Oscar S.H. Chan et al, 2014, Oral Oncology CrossRef
  18. Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma
    Rou Jiang et al, 2014, Med Oncol CrossRef
  19. Prognostic Factors on Overall Survival of Newly Diagnosed Metastatic Nasopharyngeal Carcinoma
    Jia-Xin Li et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  20. Retrograde Analysis of Clinical Characteristics of Bone Metastasis in 1,031 Cases of Preliminarily Diagnosed Nasopharyngeal Carcinoma
    Chang-Lin Zhao et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  21. Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma
    Qiuyuan Wen et al, 2014, PLoS ONE CrossRef
  22. Oligometastatic disease
    Amy TY Chang et al, 2014 CrossRef
  23. Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma
    Qian Zhu et al, 2016, Tumor Biol. CrossRef
  24. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma
    Lujun Shen et al, 2016, Radiology CrossRef
  25. Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature
    Pietro Genova et al, 2016, World J Surg Onc CrossRef
  26. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
    Li Zhang et al, 2016, The Lancet CrossRef
  27. Management of Nasopharyngeal Carcinoma
    Wai Tong Ng et al, 2016 CrossRef
  28. Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance
    Xue-Song Sun et al, 2019, Cancer Res Treat CrossRef
  29. Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis
    Yun-ming Tian et al, 2019, Sci Rep CrossRef
  30. M1 Stage Subdivision and Treatment Outcome of Patients With Bone‐Only Metastasis of Nasopharyngeal Carcinoma
    Lujun Shen et al, 2015, The Oncologist CrossRef
  31. Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines
    Guan-Qun Zhou et al, 2020, Front. Oncol. CrossRef
  32. Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases
    Tianying Huang et al, 2020, Head & Neck CrossRef
  33. Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis
    Wang Li et al, 2017, Oncotarget CrossRef
  34. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States
    Yali Xu et al, 2020, The Laryngoscope CrossRef
  35. Synchronous Metastatic Nasopharyngeal Carcinoma: Characteristics and Survival of Patients Adding Definitive Nasopharyngeal-Neck Radiotherapy to Systematic Chemotherapy


    Wenjun Liao et al, 2020, CMAR CrossRef
  36. Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy
    W.-Z. Li et al, 2021, ESMO Open CrossRef
  37. Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma
    David Johnson et al, 2021, Oral Oncology CrossRef
  38. Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas
    Mei Lin et al, 2021, Oral Oncology CrossRef
  39. Management of Radiation-Induced Late Complications and Evidence-Based Surveillance for Nasopharyngeal Carcinoma
    Yingzhi Wu et al, 2021 CrossRef
  40. Immunotherapy in Recurrent and Metastatic Nasopharyngeal Carcinoma
    Brigette B. Y. Ma et al, 2022 CrossRef
  41. Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP
    Rasheed Omobolaji Alabi et al, 2023, Sci Rep CrossRef
  42. Construction of Prognostic Nomogram in Patients with N3-Stage Nasopharyngeal Carcinoma
    Wenmiao Cao et al, 2023, ORL CrossRef
  43. Targeted Therapy and Immunotherapy for Nasopharyngeal Carcinoma
    Brigette B. Y. Ma et al, 2023 CrossRef
  44. Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study
    Yang Liu et al, 2024, Oral Oncology CrossRef
  45. Locoregional Radiotherapy in Metastatic Nasopharyngeal Cancer – Review Article of Recent Trials
    Ghritashee Bora et al, 2023 CrossRef